Associations between CA19-9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancer.

about

Associations between CA19-9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancer.

Item

http://www.wikidata.org/entity/Q55356265

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Associations between CA19-9 an ...... patients with gastric cancer.

@en

Associations between CA19-9 an ...... patients with gastric cancer.

@nl

type

Item

label

Associations between CA19-9 an ...... patients with gastric cancer.

@en

Associations between CA19-9 an ...... patients with gastric cancer.

@nl

prefLabel

Associations between CA19-9 an ...... patients with gastric cancer.

@en

Associations between CA19-9 an ...... patients with gastric cancer.

@nl

P1476

Associations between CA19-9 an ...... n patients with gastric cancer

@en

P2093

Ailian Dong

http://www.w3.org/2001/XMLSchema#string

Guangmei He

http://www.w3.org/2001/XMLSchema#string

Hongbo Zhou

http://www.w3.org/2001/XMLSchema#string

Hui Xia

http://www.w3.org/2001/XMLSchema#string

Jianghe Cui

http://www.w3.org/2001/XMLSchema#string

P2860

HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach

Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer.

Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.

Clinical impact of tumour biology in the management of gastroesophageal cancer

Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia-Pacific task force

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer

Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.

Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer.

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

P304

1079-1086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8731

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29963185

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

6019918

http://www.w3.org/2001/XMLSchema#string